![David Schnell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Schnell
Gründer bei
Prospect Venture Partners
Profil
David Schnell is the founder and currently holds the position of Managing Director at Prospect Venture Partners, a company he founded in 1997.
He is also currently the Director at Panmira Pharmaceuticals LLC and the Managing Director at Iconica LLC.
In the past, Dr. Schnell has held positions as Director at Neurocrine Biosciences, Inc., Essential Therapeutics, Inc., Emdeon Corp., Senomyx, Inc., Emergent Product Development Seattle, Gloucester Pharmaceuticals, Inc., Satori Pharmaceuticals, Inc., Amira Pharmaceuticals, Inc., Kythera Biopharmaceuticals LLC, Lux Biosciences, Inc., Alvine Pharmaceuticals, Inc., NGM Biopharmaceuticals, Inc., Trine Pharmaceuticals, Inc., Rinat Neuroscience Corp., Nora Therapeutics, Inc., Healtheon, Inc., Microcide, Inc., and Sandoz Pharmaceuticals Corp.
Dr. Schnell's education includes an undergraduate degree from Stanford University in 1982, a doctorate from Harvard Medical School in 1987, and a graduate degree from Stanford University School of Medicine in 1982.
Aktive Positionen von David Schnell
| Unternehmen | Position | Beginn |
|---|---|---|
Prospect Venture Partners
 Prospect Venture Partners Investment ManagersFinance Prospect Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and biomedical innovation sectors. It provides financing for seed, early and growth stage capital requirements. | Gründer | 01.01.1997 |
Panmira Pharmaceuticals LLC
 Panmira Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug development programs for inflammatory diseases | Direktor/Vorstandsmitglied | - |
Iconica LLC
 Iconica LLC Investment ManagersFinance Iconica Partners invests in companies located in the United States. The firm targets companies operating in the fields of sports, media, entertainment and technology. It provides financing for seed and early stage capital requirements. | Private Equity Investor | - |
Ehemalige bekannte Positionen von David Schnell
| Unternehmen | Position | Ende |
|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 08.06.2021 |
| KYTHERA BIOPHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 31.12.2014 |
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of cancer patients | Direktor/Vorstandsmitglied | 26.04.2011 |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Direktor/Vorstandsmitglied | 28.10.2010 |
Trine Pharmaceuticals, Inc.
 Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Direktor/Vorstandsmitglied | 19.09.2008 |
Ausbildung von David Schnell
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
25
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 25 |
|---|---|
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Essential Therapeutics, Inc.
 Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical goods for viral and fungal infections | Health Technology |
Emdeon Corp.
 Emdeon Corp. Data Processing ServicesTechnology Services Develops Internet-based information and transaction processing of health care information systems | Technology Services |
Senomyx, Inc.
 Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Discovers and develops novel flavors and taste modulators for the packaged food and beverage industry | Consumer Non-Durables |
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Health Technology |
Gloucester Pharmaceuticals, Inc.
Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of cancer patients | Health Technology |
Satori Pharmaceuticals, Inc.
 Satori Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for alzheimer's disease | Health Technology |
Amira Pharmaceuticals, Inc.
 Amira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes novel dermatology prescription drugs | Health Technology |
Lux Biosciences, Inc.
 Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat ophthalmic diseases | Health Technology |
Alvine Pharmaceuticals, Inc.
 Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes therapeutics for inflammatory diseases | Health Technology |
NGM Biopharmaceuticals, Inc.
 NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kleiner Perkins Caufield & Byers LLC
 Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers invests in companies located in the United States. The firm targets companies operating in consumer, enterprise, Fintech, hardtech and healthcare sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Prospect Venture Partners
Prospect Venture Partners Investment ManagersFinance Prospect Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and biomedical innovation sectors. It provides financing for seed, early and growth stage capital requirements. | Finance |
Trine Pharmaceuticals, Inc.
Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Rinat Neuroscience Corp.
 Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Health Technology |
Sandoz Pharmaceuticals Corp. | |
Nora Therapeutics, Inc.
 Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments for infertility and miscarriages | Health Technology |
Healtheon, Inc.
 Healtheon, Inc. Medical/Nursing ServicesHealth Services Provides medical diagnostic and information technology services | Health Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Panmira Pharmaceuticals LLC
Panmira Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug development programs for inflammatory diseases | Health Technology |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iconica LLC
Iconica LLC Investment ManagersFinance Iconica Partners invests in companies located in the United States. The firm targets companies operating in the fields of sports, media, entertainment and technology. It provides financing for seed and early stage capital requirements. | Finance |
Microcide, Inc.
 Microcide, Inc. BiotechnologyHealth Technology Biotechnology company that develops nontoxic antimicrobial products | Health Technology |
